SO
CUE icon

STRS Ohio’s Cue Biopharma CUE Stock Holding History

STRS Ohio’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-683
Closed -$308K – 2184
2020
Q3 		$308K Sell
683
-147
-18% -$84.7K ﹤0.01% 1557
2020
Q2 		$610K Sell
830
-110
-12% -$79.7K ﹤0.01% 1166
2020
Q1 		$400K Hold
940
– – ﹤0.01% 1302
2019
Q4 		$447K Hold
940
– – ﹤0.01% 1481
2019
Q3 		$237K Buy
940
+440
+88% +$106K ﹤0.01% 1602
2019
Q2 		$134K Buy
500
+417
+502% +$104K ﹤0.01% 1767
2019
Q1 		$19K Hold
83
– – ﹤0.01% 1969
2018
Q4 		$11K Hold
83
– – ﹤0.01% 2022
2018
Q3 		$22K Hold
83
– – ﹤0.01% 2032
2018
Q2 		$29K Hold
83
– – ﹤0.01% 2033
2018
Q1 		$35K Buy
+83
New +$37.8K ﹤0.01% 1780

Other funds holding CUE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

STRS Ohio's CUE Position: Q4 2020 in Review

STRS Ohio sold out of Cue Biopharma (CUE) in Q4 2020, closing a stake of 683 shares — an estimated $308K sold.

STRS Ohio first reported a position in CUE in Q1 2018 and held it in 11 quarters. The position peaked at $610K in Q2 2020. 97 funds tracked by Wall St. Rank hold CUE as of Q4 2020.

  • STRS Ohio reported no remaining Cue Biopharma position as of Q4 2020 after selling out during the quarter.
  • STRS Ohio sold 683 Cue Biopharma shares in Q4 2020, an estimated $308K.
  • STRS Ohio first reported a position in Cue Biopharma in Q1 2018 and held it in 11 quarters.
  • STRS Ohio's Cue Biopharma position peaked at $610K in Q2 2020.
  • 97 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.